Conformis Inc. (NASDAQ:CFMS) has a beta of 1.34. The stock’s Relative Strength Index (RSI) is 55.33, with weekly volatility at 10.33% and ATR at 0.17. The CFMS stock’s 52-week price range has touched low of $0.50 and a $1.49 high. Its shares traded higher over the last trading session, gaining 15.89% on 02/22/21. The shares fell to a low of $1.12 before closing at $1.24. Intraday shares traded counted 53.02 million, which was -1356.55% lower than its 30-day average trading volume of 3.64M. CFMS’s previous close was $1.07 while the outstanding shares total 95.55M.
Investors have identified the Medical Devices company Conformis Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $229.11 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Conformis Inc. (CFMS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CFMS, the company has in raw cash 32.89 million on their books with 14.0 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 61.33 million total, with 32.27 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.35 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CFMS sounds very interesting.
Is the stock of CFMS attractive?
In related news, CFO & TREASURER, HOWE ROBERT S sold 11,206 shares of the company’s stock in a transaction that recorded on Feb 17. The sale was performed at an average price of 1.19, for a total value of 13,335. As the sale deal closes, the President & CEO, Augusti Mark A now sold 32,260 shares of the company’s stock, valued at 24,127. Also, President & CEO, Augusti Mark A sold 61,025 shares of the company’s stock in a deal that was recorded on Jan 04. The shares were price at an average price of 0.64 per share, with a total market value of 39,160. Following this completion of acquisition, the President & CEO, Augusti Mark A now holds 2,238 shares of the company’s stock, valued at 1,455. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.30%.